Bisphosphonate-induced Severe Hypocalcemia - A Case Report -
Won-Seok Do, Jin-Kyung Park, Myung-Il Park, Hyeong-Seok Kim, Sung-Ho Kim, Duk-Hyun Lee
J Bone Metab. 2012;19(2):139-145.   Published online 2012 Nov 16     DOI: https://doi.org/10.11005/jbm.2012.19.2.139
Citations to this article as recorded by Crossref logo
Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients
H. McKee, G. Ioannidis, A. Lau, D. Treleaven, A. Gangji, C. Ribic, M. Wong-Pack, A. Papaioannou, J. D. Adachi
Osteoporosis International.2020; 31(5): 973.     CrossRef
Prolonged use of alendronate alters the biology of cranial repair in estrogen-deficient rats’ associated simultaneous immunohistochemical expression of TGF-β1+, α-ER+, and BMPR1B-
Allan Fernando Giovanini, Giuliene Nunes de Sousa Passoni, Isabella Göhringer, Tatiana Miranda Deliberador, João Cesar Zielak, Carmem Lucia Muller Storrer, Thais Andrade Costa - Casagrande, Rafaela Scariot
Clinical Oral Investigations.2018; 22(5): 1959.     CrossRef
Treatment of severe hypocalcaemia due to osteoblastic metastases in a patient with post-thyroidectomy hypoparathyroidism with153Sm-EDTMP
Eva Kassi, Ifigeneia Kapsali, Michalis Kokkinos, Helen Gogas
BMJ Case Reports.2017; : bcr-2017-219354.     CrossRef